T Baglin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAnticoagulants/administration & dosageHeparin/administration & dosageHumansPostthrombotic Syndrome/etiologyPostthrombotic Syndrome/prevention & controlVenous Thrombosis/complicationsVenous Thrombosis/drug therapy
Substances: See more » AnticoagulantsHeparin
Year: 2012 PMID: 22672412 DOI: 10.1111/j.1538-7836.2012.04806.x
Source DB: PubMed Journal: J Thromb Haemost ISSN: 1538-7836 Impact factor: 5.824